Ignite Creation Date:
2024-05-06 @ 1:09 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03942094
Status:
UNKNOWN
Last Update Posted:
2022-03-16
First Post:
2019-05-06
Brief Title:
Nilotinib for First-line Newly Diagnosed CML-CP Patients
Sponsor:
Organization:
Shenzhen Second Peoples Hospital